ATLAS LITHIUM INC (ATLX)

US1058613068 - Common Stock

7.3  +0.11 (+1.53%)

After market: 7.3 0 (0%)

Fundamental Rating

2

Overall ATLX gets a fundamental rating of 2 out of 10. We evaluated ATLX against 154 industry peers in the Metals & Mining industry. Both the profitability and financial health of ATLX have multiple concerns. ATLX has a valuation in line with the averages, but on the other hand it scores bad on growth.



1

1. Profitability

1.1 Basic Checks

ATLX had negative earnings in the past year.
In the past year ATLX has reported a negative cash flow from operations.
ATLX had negative earnings in each of the past 5 years.
ATLX had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

ATLX's Return On Assets of -101.08% is on the low side compared to the rest of the industry. ATLX is outperformed by 97.96% of its industry peers.
Looking at the Return On Equity, with a value of -262.64%, ATLX is doing worse than 94.56% of the companies in the same industry.
Industry RankSector Rank
ROA -101.08%
ROE -262.64%
ROIC N/A
ROA(3y)-117.95%
ROA(5y)-130.88%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

ATLX has a better Gross Margin (45.78%) than 85.71% of its industry peers.
ATLX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.78%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

ATLX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ATLX has more shares outstanding
ATLX has more shares outstanding than it did 5 years ago.
ATLX has a worse debt/assets ratio than last year.

2.2 Solvency

ATLX has an Altman-Z score of -4.42. This is a bad value and indicates that ATLX is not financially healthy and even has some risk of bankruptcy.
ATLX has a Altman-Z score of -4.42. This is amonst the worse of the industry: ATLX underperforms 93.88% of its industry peers.
ATLX has a Debt/Equity ratio of 0.42. This is a healthy value indicating a solid balance between debt and equity.
ATLX has a Debt to Equity ratio of 0.42. This is in the lower half of the industry: ATLX underperforms 72.79% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF N/A
Altman-Z -4.42
ROIC/WACCN/A
WACC11.28%

2.3 Liquidity

A Current Ratio of 3.54 indicates that ATLX has no problem at all paying its short term obligations.
With a decent Current ratio value of 3.54, ATLX is doing good in the industry, outperforming 67.35% of the companies in the same industry.
ATLX has a Quick Ratio of 3.45. This indicates that ATLX is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of ATLX (3.45) is better than 74.83% of its industry peers.
Industry RankSector Rank
Current Ratio 3.54
Quick Ratio 3.45

1

3. Growth

3.1 Past

The earnings per share for ATLX have decreased strongly by -10.24% in the last year.
Looking at the last year, ATLX shows a very negative growth in Revenue. The Revenue has decreased by -100.00% in the last year.
EPS 1Y (TTM)-10.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.95%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, ATLX will show a very strong growth in Earnings Per Share. The EPS will grow by 53.74% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y29.4%
EPS Next 2Y53.74%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

4

4. Valuation

4.1 Price/Earnings Ratio

ATLX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 4.95 indicates a rather cheap valuation of ATLX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ATLX indicates a rather cheap valuation: ATLX is cheaper than 94.56% of the companies listed in the same industry.
ATLX is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.73, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 4.95

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

ATLX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ATLX's earnings are expected to grow with 53.74% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y53.74%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ATLX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ATLAS LITHIUM INC

NASDAQ:ATLX (1/6/2025, 5:20:00 PM)

After market: 7.3 0 (0%)

7.3

+0.11 (+1.53%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)11-08 2024-11-08/amc
Earnings (Next)N/A N/A
Inst Owners10.26%
Inst Owner ChangeN/A
Ins Owners36.47%
Ins Owner Change6.11%
Market Cap112.57M
Analysts82.22
Price Target28.22 (286.58%)
Short Float %7.12%
Short Ratio4.67
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9.17%
Min EPS beat(2)-23.46%
Max EPS beat(2)5.12%
EPS beat(4)1
Avg EPS beat(4)-46.97%
Min EPS beat(4)-93.08%
Max EPS beat(4)5.12%
EPS beat(8)1
Avg EPS beat(8)-139.61%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-31.69%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-15.73%
EPS NY rev (1m)0%
EPS NY rev (3m)1.75%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-50%
Revenue NY rev (1m)0%
Revenue NY rev (3m)17.5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 4.95
P/S 154.12
P/FCF N/A
P/OCF N/A
P/B 4.83
P/tB 4.92
EV/EBITDA N/A
EPS(TTM)-4.09
EYN/A
EPS(NY)1.48
Fwd EY20.21%
FCF(TTM)-3.35
FCFYN/A
OCF(TTM)-1.46
OCFYN/A
SpS0.05
BVpS1.51
TBVpS1.48
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -101.08%
ROE -262.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.78%
FCFM N/A
ROA(3y)-117.95%
ROA(5y)-130.88%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 16297.5%
Cap/Sales 3987.07%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.54
Quick Ratio 3.45
Altman-Z -4.42
F-Score2
WACC11.28%
ROIC/WACCN/A
Cap/Depr(3y)12975.7%
Cap/Depr(5y)7789.4%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.95%
EPS Next Y29.4%
EPS Next 2Y53.74%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-127.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1351.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2225.42%
OCF growth 3YN/A
OCF growth 5YN/A